Sanofi Pasteur's Mark Lievonen Honoured For Commitment to Biotechnology
Industry by Canadian Healthcare Marketing Hall of Fame
30-year Industry Veteran Advocate for Advancing Science, Innovation and
TORONTO, April 11, 2013 /CNW/ - Mark Lievonen, President of Sanofi Pasteur
Limited, the Canadian vaccine division of the Sanofi Group, has been inducted
into the 2013 Canadian Marketing Healthcare Hall of Fame Award, in recognition
of his outstanding contributions to the healthcare industry.
The Canadian Healthcare Marketing Hall of Fame was established in 1988 to
honour lifetime achievement in healthcare marketing. This award is the
highlight of the annual National Pharmaceutical Congress organized by the
"Through a career spanning over 30 years, Mark Lievonen has made a lasting
impact on the industry and served as a source of inspiration to others," said
Mitchell Shannon, Publisher, The Chronicle Newspapers, which sponsors the
award. "The judging committee was impressed by Mr. Lievonen's extraordinary
dedication and commitment to the profession. Under his leadership, Sanofi
Pasteur has become a billion dollar enterprise in Canada, and is a symbol of
Canadian talent, innovation and R&D excellence."
Lievonen is an active member in the life sciences sector. He is a member of
several organizations, notably: Director, Oncolytics Biotech Inc.; Vice-Chair,
Ontario Institute for Cancer Research; First Vice-Chair, Rx&D; Chair, Markham
Stouffville Hospital Foundation; Director, Public Policy Forum; Governor, York
University; Director, BIOTECanada; Director, Markham Stouffville Hospital; and
Director, York University Development Corporation.
"I am truly honoured to receive this recognition on behalf of Sanofi Pasteur,
my colleagues and my community, and I am proud that we have been able to play
a small part in preventing disease and saving lives in Canada and all around
the world," says Mark Lievonen. "I am energized by the work we do, inspired
by my passionate colleagues and humbled by our role in impacting human lives
each and every day."
Lievonen has been the recipient of the Queen's Golden Jubilee Medallion
(2002), the Chevalier de l'Ordre National de Mérite by the Government of
France (2007), Fellow, Ontario Institute of Chartered Accountants (2009) and
received the Queen's Diamond Jubilee Medallion (2012). Twenty years ago,
Lievonen also spearheaded Canada's only mentored science competition, the
Sanofi BioGENEius Challenge Canada (SBCC), to foster biotechnology talent in
Canada among high school students. For a complete biography click here.
Mark Lievonen joined Sanofi Pasteur Canada in 1983 and has been the President
since 1999. For almost 100 years, Sanofi Pasteur has been at the forefront of
innovation in vaccine R&D, and has made more than $600 million in capital
expenditures since 2000. The company manufactures over 50 million doses of
vaccines in Canada for both domestic and international markets, and is the
only manufacturer of 5-component acellular pertussis combination vaccines,
which was launched in Canada as Pentacel® in 1997. Sanofi Pasteur has a
broad vaccine portfolio in Canada, including Pediacel®, Menactra®, Adacel®,
Intanza®, Vaxigrip®, ViVaxim®, Typhim Vi® and YF-Vax®.
Nominations for the 2013 selection of honorees were solicited during the past
months from the publication's readers. Since 1988, 95 healthcare
visionaries, original thinkers and leaders have been honoured with this
prestigious distinction. Numerous submissions were received and a committee
consisting of the publications' editors and an ad hoc group of industry
advisors undertook the difficult task of determining from among the Nominees
the candidates who best exemplified the qualities described above, based on
the information submitted by the individual(s) making the nomination.
Sanofi, a global and diversified healthcare leader, discovers, develops and
distributes therapeutic solutions focused on patients' needs. Sanofi has core
strengths in the field of healthcare with seven growth platforms: diabetes
solutions, human vaccines, innovative drugs, rare diseases, consumer
healthcare, emerging markets and animal health. Sanofi is listed in Paris
(EURONEXT: SAN) and in New York (NYSE: SNY).
Sanofi Pasteur, the vaccines division of Sanofi, provides more than 1 billion
doses of vaccine each year, making it possible to immunize more than 500
million people across the globe. A world leader in the vaccine industry,
Sanofi Pasteur offers the broadest range of vaccines protecting against 20
infectious diseases. The company's heritage, to create vaccines that protect
life, dates back more than a century. Sanofi Pasteur is the largest company
entirely dedicated to vaccines. Every day, the company invests more than EUR 1
million in research and development. For more information, please visit:
Media Contacts: Nancy Simpson Sanofi Pasteur Tel: 416-667-2955
Kara LATTA CASACOM Tel: 416-944-2145 email@example.com
Image with caption: "Mark Lievonen, President, Sanofi Pasteur Limited is
inducted into the Canadian Healthcare Marketing Hall of Fame Award by Mitchell
Shannon, Publisher, The Chronicle Newspapers at the Canadian Pharmaceutical
Congress, held yesterday at the Mississauga Convention Centre. (CNW
Group/Sanofi Pasteur Inc.)". Image available at:
SOURCE: Sanofi Pasteur Inc.
To view this news release in HTML formatting, please use the following URL:
CO: Sanofi Pasteur Inc.
NI: BTC MTC ENT
-0- Apr/11/2013 17:13 GMT
Press spacebar to pause and continue. Press esc to stop.